EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Inflammation, Lifestyle Factors, and the Microbiome‐Gut‐Brain Axis: Relevance to Depression and Antidepressant Action

Francisco Donoso iD, John F Cryan, Loreto Olavarría-Ramírez, Yvonne M Nolan, Gerard Clarke

Clinical Pharmacology & Therapeutics · 2023-02 · 113 (2) · 246-259

DOI: 10.1002/cpt.2581 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 05.04.2022. Verfasst von Francisco Donoso und 4 weiteren Autor:innen. Beteiligte Einrichtung: Alimentary Pharmabiotic Centre Microbiome Ireland, University College Cork, Cork, Ireland. Hauptthemen laut MEDLINE: Brain-Gut Axis, Depression. Die Arbeit wurde bisher 125-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science Foundation Ireland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is considered a major public health concern, where existing pharmacological treatments are not equally effective across all patients. The pathogenesis of depression involves the interaction of complex biological components, such as the immune system and the microbiota‐gut‐brain axis. Adjunctive lifestyle‐oriented approaches for depression, including physical exercise and special diets are promising therapeutic options when combined with traditional antidepressants. However, the mechanisms of action of these strategies are incompletely understood. Accumulating evidence suggests that physical exercise and specific dietary regimens can modulate both the immune system and gut microbiota composition. Here, we review the current information about the strategies to alleviate depression and their crosstalk with both inflammatory mechanisms and the gut microbiome. We further discuss the role of the microbiota‐gut‐brain axis as a possible mediator for the adjunctive therapies for depression through inflammatory mechanisms. Finally, we review existing and future adjunctive strategies to manipulate the gut microbiota with potential use for depression, including physical exercise, dietary interventions, prebiotics/probiotics, and fecal microbiota transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain-Gut AxisDepressionHumansAntidepressive AgentsInflammationLife Style

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Alimentary Pharmabiotic Centre Microbiome Ireland, University College Cork, Cork, Ireland.
  • Department of Anatomy & Neuroscience, University College Cork, Cork, Ireland.
  • Department of Psychiatry & Neurobehavioural Science, University College Cork, Cork, Ireland.

ORCID-Profile: Francisco Donoso

Förderung

  • Science Foundation Ireland

Zitieren

APA

Donoso, F., Cryan, J. F., Olavarría-Ramírez, L., Nolan, Y. M., & Clarke, G. (2023). Inflammation, Lifestyle Factors, and the Microbiome‐Gut‐Brain Axis: Relevance to Depression and Antidepressant Action. Clinical Pharmacology & Therapeutics, 113(2), 246-259. https://doi.org/10.1002/cpt.2581

Vancouver

Donoso F, Cryan JF, Olavarría-Ramírez L, Nolan YM, Clarke G. Inflammation, Lifestyle Factors, and the Microbiome‐Gut‐Brain Axis: Relevance to Depression and Antidepressant Action. Clinical Pharmacology & Therapeutics. 2023;113(2):246-259. doi:10.1002/cpt.2581

BibTeX
@article{Donoso2023,
  author = {Donoso, Francisco and Cryan, John F and Olavarría-Ramírez, Loreto and Nolan, Yvonne M and Clarke, Gerard},
  title = {Inflammation, Lifestyle Factors, and the Microbiome‐Gut‐Brain Axis: Relevance to Depression and Antidepressant Action},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2023},
  volume = {113},
  number = {2},
  pages = {246--259},
  doi = {10.1002/cpt.2581}
}
Kostenlos starten →